Castillo I - Search Results

1

Long term clinical outcome of chronic hepatitis C patients with sustained virological response to interferon monotherapy.

Veldt BJ, Saracco G, Boyer N, Cammà C, Bellobuono A, Hopf U, Castillo I, Weiland O, Nevens F, Hansen BE, Schalm SW. Veldt BJ, et al. Among authors: castillo i. Gut. 2004 Oct;53(10):1504-8. doi: 10.1136/gut.2003.038257. Gut. 2004. PMID: 15361504 Free PMC article. Review.

2

Virological and biochemical long-term follow-up of patients with chronic hepatitis C treated with interferon.

Castillo I, Bartolomé J, Navas S, Gonzalez S, Herrero M, Carreño V. Castillo I, et al. Hepatology. 1994 Jun;19(6):1342-6. Hepatology. 1994. PMID: 8188165 Clinical Trial.

3

Long-term follow-up of hepatitis B chronic carriers who responded to interferon therapy.

Carreño V, Castillo I, Molina J, Porres JC, Bartolomé J. Carreño V, et al. Among authors: castillo i. J Hepatol. 1992 May;15(1-2):102-6. doi: 10.1016/0168-8278(92)90019-l. J Hepatol. 1992. PMID: 1380526

4

Immunoglobulin M antibody to hepatitis C virus during interferon therapy for chronic hepatitis C.

Quiroga JA, Bosch O, Gonzalez R, Marriott E, Castillo I, Bartolome J, Carreño V. Quiroga JA, et al. Among authors: castillo i. Gastroenterology. 1992 Oct;103(4):1285-9. doi: 10.1016/0016-5085(92)91517-8. Gastroenterology. 1992. PMID: 1383071 Clinical Trial.

5

Long-term effect of interferon therapy in chronic hepatitis B.

Carreño V, Bartolomé J, Castillo I. Carreño V, et al. Among authors: castillo i. J Hepatol. 1994 Mar;20(3):431-5. doi: 10.1016/s0168-8278(94)80021-9. J Hepatol. 1994. PMID: 7516953 Review. No abstract available.

6

Prolonged treatment (18 months) of chronic hepatitis C with recombinant alpha-interferon in comparison with a control group.

Gómez-Rubio M, Porres JC, Castillo I, Quiroga JA, Moreno A, Carreño V. Gómez-Rubio M, et al. Among authors: castillo i. J Hepatol. 1990;11 Suppl 1:S63-7. doi: 10.1016/0168-8278(90)90166-o. J Hepatol. 1990. PMID: 2127790 Clinical Trial.

7

A pilot study of recombinant interleukin-2 for treatment of chronic hepatitis C.

Pardo M, Castillo I, Oliva H, Fernández-Flores A, Bárcena R, de Peuter MA, Carreño V. Pardo M, et al. Among authors: castillo i. Hepatology. 1997 Nov;26(5):1318-21. doi: 10.1002/hep.510260533. Hepatology. 1997. PMID: 9362378 Clinical Trial.

8

Treatment with recombinant alpha-interferon of chronic hepatitis C in anti-HIV-positive patients.

Marriott E, Navas S, del Romero J, García S, Castillo I, Quiroga JA, Carreño V. Marriott E, et al. Among authors: castillo i. J Med Virol. 1993 Jun;40(2):107-11. doi: 10.1002/jmv.1890400206. J Med Virol. 1993. PMID: 8395552

9

Protein composition of the hepatitis B virus e antigen in the natural course of disease and following interferon therapy.

Campillo ML, Quiroga JA, Bartolomé J, Moraleda G, Castillo I, Carreño V. Campillo ML, et al. Among authors: castillo i. J Clin Microbiol. 1992 May;30(5):1256-61. doi: 10.1128/jcm.30.5.1256-1261.1992. J Clin Microbiol. 1992. PMID: 1374762 Free PMC article.

10

High doses of recombinant alpha-interferon or gamma-interferon for chronic hepatitis C: a randomized, controlled trial.

Sáez-Royuela F, Porres JC, Moreno A, Castillo I, Martinez G, Galiana F, Carreño V. Sáez-Royuela F, et al. Among authors: castillo i. Hepatology. 1991 Feb;13(2):327-31. doi: 10.1002/hep.1840130220. Hepatology. 1991. PMID: 1899852 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

443 results

Search Page

Filters